DZ Bank’s Assembly Biosciences ASMB Stock Holding History

DZ Bank’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-368	Closed	-$217K	–	863
2018 Q1	$217K	Buy	+368	New	+$228K	﹤0.01%	921

Other funds holding ASMB

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DZ Bank's ASMB Position: Q2 2018 in Review

DZ Bank sold out of Assembly Biosciences (ASMB) in Q2 2018, closing a stake of 368 shares — an estimated $217K sold.

DZ Bank first reported a position in ASMB in Q1 2018 and held it in 1 quarter. The position peaked at $217K in Q1 2018. 105 funds tracked by Wall St. Rank hold ASMB as of Q2 2018.

DZ Bank reported no remaining Assembly Biosciences position as of Q2 2018 after selling out during the quarter.
DZ Bank sold 368 Assembly Biosciences shares in Q2 2018, an estimated $217K.
DZ Bank first reported a position in Assembly Biosciences in Q1 2018 and held it in 1 quarter.
DZ Bank's Assembly Biosciences position peaked at $217K in Q1 2018.
105 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2018.

Based on DZ Bank's 13F filing for Q2 2018, filed 14 Aug 2018.